ENTA vs. CAPR
ENTA (Enanta Pharmaceuticals, Inc.) and CAPR (Capricor Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 10 years, ENTA returned -7.18%/yr vs -2.03%/yr for CAPR. At a 0.15 correlation, their price movements are largely independent.
Performance
ENTA vs. CAPR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ENTA achieves a -29.80% return, which is significantly lower than CAPR's -9.36% return. Over the past 10 years, ENTA has underperformed CAPR with an annualized return of -7.18%, while CAPR has yielded a comparatively higher -2.03% annualized return.
ENTA
- 1D
- -1.86%
- 1M
- -27.84%
- YTD
- -29.80%
- 6M
- -21.93%
- 1Y
- 48.19%
- 3Y*
- -24.76%
- 5Y*
- -25.36%
- 10Y*
- -7.18%
CAPR
- 1D
- -2.06%
- 1M
- -13.89%
- YTD
- -9.36%
- 6M
- -8.40%
- 1Y
- 83.84%
- 3Y*
- 77.22%
- 5Y*
- 42.20%
- 10Y*
- -2.03%
ENTA vs. CAPR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ENTA Enanta Pharmaceuticals, Inc. | -29.80% | 174.26% | -38.89% | -79.77% | -37.79% | 77.62% | -31.85% | -12.78% | 20.71% | 75.16% |
CAPR Capricor Therapeutics, Inc. | -9.36% | 109.13% | 182.21% | 26.68% | 31.74% | -14.58% | 167.97% | -68.78% | -74.05% | -40.60% |
Correlation
The correlation between ENTA and CAPR is 0.18, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.18 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since Mar 22, 2013 | 0.15 |
Fundamentals
ENTA:
$319.83M
CAPR:
$1.50B
ENTA:
-$2.67
CAPR:
-$2.32
ENTA:
2.77
CAPR:
0.01
ENTA:
$69.21M
CAPR:
$0.00
ENTA:
$33.44M
CAPR:
-$42.41M
ENTA:
-$61.85M
CAPR:
-$117.24M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ENTA vs. CAPR — Risk / Return Rank
ENTA
CAPR
ENTA vs. CAPR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Enanta Pharmaceuticals, Inc. (ENTA) and Capricor Therapeutics, Inc. (CAPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ENTA | CAPR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.22 | ||
| Sortino ratioReturn per unit of downside risk | -2.62 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.59 | -0.35 |
| Calmar ratioReturn relative to maximum drawdown | 1.41 | 1.26 | +0.15 |
| Martin ratioReturn relative to average drawdown | 2.72 | 2.38 | +0.34 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ENTA | CAPR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.44 | 0.22 | +0.22 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.35 | 0.22 | -0.57 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.12 | -0.01 | -0.11 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.05 | -0.08 | +0.03 |
Drawdowns
ENTA vs. CAPR - Drawdown Comparison
The maximum ENTA drawdown since its inception was -96.63%, roughly equal to the maximum CAPR drawdown of -99.97%. Use the drawdown chart below to compare losses from any high point for ENTA and CAPR.
Loading charts...
Drawdown Indicators
| ENTA | CAPR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.63% | -99.97% | +3.34% |
Max Drawdown (1Y)Largest decline over 1 year | -34.30% | -67.00% | +32.70% |
Max Drawdown (3Y)Largest decline over 3 years | -83.61% | -79.08% | -4.53% |
Max Drawdown (5Y)Largest decline over 5 years | -95.62% | -79.08% | -16.54% |
Max Drawdown (10Y)Largest decline over 10 years | -96.63% | -98.02% | +1.39% |
Current DrawdownCurrent decline from peak | -91.24% | -99.20% | +7.96% |
Average DrawdownAverage peak-to-trough decline | -49.23% | -90.24% | +41.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.76% | 35.96% | -18.20% |
Volatility
ENTA vs. CAPR - Volatility Comparison
The current volatility for Enanta Pharmaceuticals, Inc. (ENTA) is 13.36%, while Capricor Therapeutics, Inc. (CAPR) has a volatility of 18.21%. This indicates that ENTA experiences smaller price fluctuations and is considered to be less risky than CAPR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ENTA | CAPR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.36% | 18.21% | -4.85% |
Volatility (6M)Calculated over the trailing 6-month period | 35.53% | 50.01% | -14.48% |
Volatility (1Y)Calculated over the trailing 1-year period | 109.93% | 385.34% | -275.41% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 73.36% | 190.06% | -116.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 60.70% | 179.86% | -119.16% |
Dividends
ENTA vs. CAPR - Dividend Comparison
Neither ENTA nor CAPR has paid dividends to shareholders.
Financials
ENTA vs. CAPR - Financials Comparison
This section allows you to compare key financial metrics between Enanta Pharmaceuticals, Inc. and Capricor Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ENTA and CAPR have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CAPR has higher volatility (18.21%) compared to ENTA (13.36%). In terms of maximum drawdown, ENTA dropped -96.63% vs CAPR's -99.97%.
ENTA currently has the higher Sharpe Ratio (0.44 vs 0.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ENTA and CAPR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer